Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
Related Articles
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also published in forbes.com
- Ackman Expects 'Influence' in Air Products CEO Search also written by Antoine Gara
- Six Years Later, The Problem at HP is Still the Board also published in forbes.com
- DuPont's Activist Response Has Perfect Formula To Counter Trian's Nelson Peltz also written by Antoine Gara
- A New Diversity Monitor for the S.E.C. - NYTimes.com also categorized in BoardMoves
- Yahoo! Names Thompson CEO also categorized in BoardMoves
- Hewlett-Packard Shakes Up Management, Raises Outlook also mentions Management
- Microsoft Adds New Board Member also categorized in BoardMoves
- No Sleep Till Activism: Hedge Fund H Partners Wins Mattress Company Fight also written by Antoine Gara
- Family Dollar Sees 'Virtual Certainty' Of Antitrust Clearance For Dollar Tree Merger also written by Antoine Gara
Login to comment.